DNA treatment cuts bad cholesterol by nearly 50% without statins
A new gene-editing DNA treatment may permanently reduce bad cholesterol by nearly 50% through a single administration, bypassing the need for statins.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
📍 How it ended
Researchers in British Columbia participated in gene-editing trials for heart disease prevention alongside US and China trials investigating a single nanodrug shot or IV drip to lower bad cholesterol. Scientists developed a single DNA treatment and jab reported to cut bad cholesterol levels by nearly 50 percent without statins.
The coverage quieted without a definitive conclusion regarding the permanence or wider availability of the treatment.
Epilogue added 56d ago, after coverage quieted.
The brief
Medical researchers are developing a DNA-based treatment designed to lower bad cholesterol levels by nearly 50% without the use of statins. This breakthrough involves a single administration, described in coverage as a "one-and-done" approach, which could potentially stop bad cholesterol permanently. The treatment is delivered via a single jab or IV drip, utilizing what is described as a nanodrug shot to achieve these results in patients. The primary goal of this medical intervention is the prevention of heart disease by fundamentally altering how the body manages cholesterol levels. Coverage from several international outlets emphasizes the global scale of the research and the methodology used.
The South China Morning Post reports that trials are currently taking place in both the United States and China. Simultaneously, The Daily Scan highlights the participation of researchers from British Columbia in these breakthrough gene-editing trials. Science Daily and The Independent focus on the efficacy of the treatment, noting its ability to cut bad cholesterol by half through a single dose, while The Times of India questions the possibility of achieving permanent results via a single IV drip. This development is significant because it offers an alternative to statins, which are the traditional pharmacological standard for managing cholesterol. By leveraging gene-editing technology and nanodrug delivery, scientists aim to move from chronic medication management to a singular, permanent solution.
The context provided by the reporting suggests a shift toward preventative heart disease strategies that target the genetic drivers of cholesterol production rather than relying on daily pill regimens that require lifelong adherence to be effective. Future developments to monitor include the results of the ongoing trials in the US and China to determine if the cholesterol reduction is indeed permanent. Observers will be looking for further data on the long-term safety and scalability of the nanodrug shot. Additionally, as researchers in British Columbia continue their participation, more specific data regarding the trial's success rates and the exact mechanism of the gene-editing process are expected to emerge from the scientific community to validate these early findings.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 63d ago.
Quick answers
How much does the DNA treatment reduce bad cholesterol?
The treatment cuts bad cholesterol levels by nearly 50%.
Where are the trials for this treatment taking place?
Trials are being conducted in the United States and China, with participation from researchers in British Columbia.
How is the treatment administered?
It is administered as a single jab, IV drip, or nanodrug shot.
Coverage (5)
- Can one IV drip lower bad cholesterol permanently? The Times of India · 67d ago
- B.C. researchers participate in breakthrough “one-and-done” gene-editing trial for heart disease prevention The Daily Scan · 67d ago
- Scientists develop single jab to cut ‘bad’ cholesterol levels by half The Independent · 67d ago
- US, China trials suggest a single nanodrug shot might stop bad cholesterol forever South China Morning Post · 67d ago
- DNA treatment cuts bad cholesterol by nearly 50% without statins Science Daily · 67d ago
Topics
Related trends
Simple salt substitute could prevent three million deaths a year worldwide, study estimates
Switching from regular salt to a potassium-enriched salt substitute worldwide could prevent nearly three million deaths annually, a study estimates.
Cellectis will shed 70% of workforce as part of in vivo pivot
Cellectis announces 70% workforce reduction and strategic pivot to in vivo gene editing as Q3 revenue drops to $14.8M.
Does a heart stent prevent future heart attacks in stable patients? 25-year follow-up offers new insight
A 25-year follow-up of the COURAGE trial found no survival benefit from early stenting in patients with stable coronary artery disease.
Two-drug therapy reduces heart artery plaque more than statins alone
New clinical study findings reveal conflicting evidence regarding the efficacy of combining statins with ezetimibe.
Strokes are happening younger; reasons and risk factors, including possible link to cannabis use
Coverage from six outlets reports that strokes and TIAs are rising among adults under 55, with possible links to cannabis use under discussion.
Why heart attacks can still happen even when bad cholesterol is low
New medical coverage explores why heart attacks can still occur in adults who maintain normal, low levels of bad cholesterol.